| Dr Francis M Phillippi Iii, MD | |
|
1800 12th St, Meridian, MS 39301-4158 | |
| (601) 703-9471 | |
| (601) 703-9936 |
| Full Name | Dr Francis M Phillippi Iii |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 45 Years |
| Location | 1800 12th St, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184610388 | NPI | - | NPPES |
| 73013141 | Other | BLUE CROSS OF AL | |
| 00115969 | Medicaid | MS | |
| 009505500 | Other | MEDICAID OF AL | |
| 220008209 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 09508 (Mississippi) | Secondary |
| 207ZP0101X | Pathology - Anatomic Pathology | 09508 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush Foundation Hospital | Meridian, MS | Hospital |
| Anderson Regional Medical Ctr | Meridian, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Inc | 9234043712 | 125 |
News Archive
PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.
Using brain imaging, researchers at Columbia University Medical Center (CUMC) have found clear differences in brain function between healthy people who carry a genetic risk factor for Alzheimer's disease and those who lack the factor.
The age at which girls reach sexual maturity is influenced by 'imprinted' genes, a small sub-set of genes whose activity differs depending on which parent passes on that gene, according to new research published today in the journal Nature.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 9 days ago
| Entity Name | Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609820539 PECOS PAC ID: 9234043712 Enrollment ID: O20031118000855 |
News Archive
PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.
Using brain imaging, researchers at Columbia University Medical Center (CUMC) have found clear differences in brain function between healthy people who carry a genetic risk factor for Alzheimer's disease and those who lack the factor.
The age at which girls reach sexual maturity is influenced by 'imprinted' genes, a small sub-set of genes whose activity differs depending on which parent passes on that gene, according to new research published today in the journal Nature.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 9 days ago
| Entity Name | Kemper Cah, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346546306 PECOS PAC ID: 5991985012 Enrollment ID: O20110622000294 |
News Archive
PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.
Using brain imaging, researchers at Columbia University Medical Center (CUMC) have found clear differences in brain function between healthy people who carry a genetic risk factor for Alzheimer's disease and those who lack the factor.
The age at which girls reach sexual maturity is influenced by 'imprinted' genes, a small sub-set of genes whose activity differs depending on which parent passes on that gene, according to new research published today in the journal Nature.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Francis M Phillippi Iii, MD 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-9471 | Dr Francis M Phillippi Iii, MD 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-9471 |
News Archive
PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.
Using brain imaging, researchers at Columbia University Medical Center (CUMC) have found clear differences in brain function between healthy people who carry a genetic risk factor for Alzheimer's disease and those who lack the factor.
The age at which girls reach sexual maturity is influenced by 'imprinted' genes, a small sub-set of genes whose activity differs depending on which parent passes on that gene, according to new research published today in the journal Nature.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 9 days ago
Karen Elizabeth Hicks, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1512 20th Ave, Meridian, MS 39301 Phone: 601-484-3494 Fax: 601-484-7776 | |
Dr. Robert L. Dean, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-4282 Fax: 601-703-4597 | |
Dr. Ralph Condon Hughes Iii, M.D. Pathology Medicare: May Accept Medicare Assignments Practice Location: 1512 20th Ave, Meridian, MS 39301 Phone: 601-483-8300 Fax: 601-484-7776 | |
Dr. Melissa Jodi Brents, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1512 20th Ave, Meridian, MS 39301 Phone: 601-483-8300 Fax: 601-484-7776 | |
Dr. Matthew Gregory Martelli, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9223 | |
Dr. Brian L Wilkinson, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1512 20th Ave, Meridian, MS 39301 Phone: 601-484-7740 |